Britain's Spectris said on Friday it has rejected a second takeover proposal from private equity firm KKR, days after the ...

The private-equity firm plans to bid against rival Advent International, which submitted a roughly $5 billion proposal.

British scientific instruments maker Spectris said it would accept a 3.73 billion pound ($5.06 billion) bid from Advent if ...

Cognito Therapeutics has reported outcomes from a post hoc analysis of its OVERTURE feasibility trial, indicating that the ...

Spectris said no further proposal from KKR has been received but that KKR has requested access to equivalent due diligence information as provided by Spectris to Advent International. KKR is reviewing ...

Spectris surged on Monday after confirming it has received a takeover proposal from private equity firm Advent International ...

Spectris shares jumped after the company said it received a 3.93 billion pound ($5.32 billion) takeover proposal from Advent International that it would be prepared to recommend to shareholders if a ...

Companies may also be using the opportunity to enter the UK market before potential further weakening of the dollar or ...

Advent's proposal valued Spectris at 37.63 pounds per share, including dividend, representing close to an 85% premium to Spectris's last closing price. Spectris, in a statement confirming a Bloomberg ...

(Reuters) -Britain's Spectris said on Friday it had rejected a second takeover proposal from private equity firm KKR, days after the scientific instruments maker backed a possible competing $5 ...

Cognito Therapeutics today announced new study results showing that its Spectris AD therapy significantly slows Alzheimer's ...